Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Solventum Corporation (SOLV)

Solventum Corporation (SOLV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,901,619
  • Shares Outstanding, K 173,493
  • Annual Sales, $ 8,325 M
  • Annual Income, $ 1,556 M
  • EBIT $ 2,181 M
  • EBITDA $ 2,670 M
  • 60-Month Beta 0.40
  • Price/Sales 1.45
  • Price/Cash Flow 7.72
  • Price/Book 2.38

Options Overview Details

View History
  • Implied Volatility 34.48% (+0.94%)
  • Historical Volatility 31.84%
  • IV Percentile 68%
  • IV Rank 33.14%
  • IV High 62.22% on 04/10/25
  • IV Low 20.73% on 12/26/25
  • Expected Move (DTE 10) 2.54 (3.76%)
  • Put/Call Vol Ratio 0.50
  • Today's Volume 84
  • Volume Avg (30-Day) 361
  • Put/Call OI Ratio 0.46
  • Today's Open Interest 8,100
  • Open Int (30-Day) 7,918
  • Expected Range 65.06 to 70.14

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 1.37
  • Number of Estimates 5
  • High Estimate 1.45
  • Low Estimate 1.33
  • Prior Year 1.34
  • Growth Rate Est. (year over year) +2.24%

Price Performance

See More
Period Period Low Period High Performance
1-Month
66.61 +1.48%
on 03/09/26
82.00 -17.56%
on 02/12/26
-12.86 (-15.98%)
since 02/10/26
3-Month
66.61 +1.48%
on 03/09/26
86.36 -21.72%
on 01/09/26
-14.30 (-17.46%)
since 12/10/25
52-Week
60.70 +11.37%
on 04/09/25
88.20 -23.36%
on 12/02/25
-10.04 (-12.93%)
since 03/10/25

Most Recent Stories

More News
Middleby Appoints Glenn Eisenberg To Board of Directors

The Middleby Corporation (NASDAQ: MIDD), a global leader in the foodservice industry, today announced the appointment of Glenn Eisenberg to its Board of Directors, effective March 1. With the addition...

SOLV : 67.60 (-1.46%)
MIDD : 150.46 (+0.39%)
LMRI : 14.45 (-1.90%)
LH : 268.70 (-1.79%)
Clover Health, Alignment Healthcare, Solventum, ANI Pharmaceuticals, and Guardant Health Shares Plummet, What You Need To Know

Clover Health, Alignment Healthcare, Solventum, ANI Pharmaceuticals, and Guardant Health Shares Plummet, What You Need To Know

SOLV : 67.60 (-1.46%)
GH : 90.49 (-0.78%)
ALHC : 18.10 (-0.66%)
ANIP : 75.96 (+1.54%)
CLOV : 1.99 (-0.50%)
Solventum’s (NYSE:SOLV) Q4 CY2025 Sales Top Estimates

Solventum’s (NYSE:SOLV) Q4 CY2025 Sales Top Estimates

SOLV : 67.60 (-1.46%)
Solventum: Q4 Earnings Snapshot

Solventum: Q4 Earnings Snapshot

SOLV : 67.60 (-1.46%)
Solventum Reports Fourth Quarter 2025 Financial Results and Introduces 2026 Full-Year Guidance

ST. PAUL, Minn. , Feb. 26, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) today reported financial results for the fourth quarter and year ended December 31, 2025.

SOLV : 67.60 (-1.46%)
What To Expect From Solventum’s (SOLV) Q4 Earnings

What To Expect From Solventum’s (SOLV) Q4 Earnings

SOLV : 67.60 (-1.46%)
1 S&P 500 Stock with Competitive Advantages and 2 We Turn Down

1 S&P 500 Stock with Competitive Advantages and 2 We Turn Down

SOLV : 67.60 (-1.46%)
VRTX : 499.17 (+8.31%)
VMC : 272.00 (-0.85%)
3 Profitable Stocks Walking a Fine Line

3 Profitable Stocks Walking a Fine Line

SOLV : 67.60 (-1.46%)
ITW : 273.29 (-1.19%)
ADUS : 102.15 (-0.69%)
Solventum Stock: Is Wall Street Bullish or Bearish?

Solventum has lagged behind the broader market over the past year, and analysts remain somewhat optimistic about the stock’s prospects.

SOLV : 67.60 (-1.46%)
XLV : 153.15 (-0.72%)
$SPX : 6,781.48 (-0.21%)
3 Value Stocks We Keep Off Our Radar

3 Value Stocks We Keep Off Our Radar

SOLV : 67.60 (-1.46%)
ROCK : 41.48 (+5.87%)
RAMP : 29.04 (-2.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Strengthening short term outlook on maintaining the current direction.

Relative Strength just crossed below 30%. The market has entered oversold territory.

See More Share

Business Summary

Solventum is an independent healthcare company. Its business segment includes Medical Surgical, Dental Solutions, Health Information Systems and Purification and Filtration. Solventum is based in ST. PAUL, Minn.

See More

Key Turning Points

3rd Resistance Point 69.96
2nd Resistance Point 69.29
1st Resistance Point 68.45
Last Price 67.60
1st Support Level 66.93
2nd Support Level 66.26
3rd Support Level 65.42

See More

52-Week High 88.20
Fibonacci 61.8% 77.69
Fibonacci 50% 74.45
Fibonacci 38.2% 71.20
Last Price 67.60
52-Week Low 60.70

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar